RETINA 2018 Speakers
• North America Lead OCT Application Specialist • Expert lecturer on use of OCT, fundus photography and fluorescein angiography • Chaired UNC Kittner Eye Center…Read More
Thomas A. Reh, PhD received his BS in Biochemistry from the University of Illinois, Champaign-Urbana in 1977 and his Ph.D. in Neuroscience from the University…Read More
Dante Pieramici is Director of the California Retina Research Foundation and a Managing Partner of The California Retina Consultants, CA, USA. He is the former…Read More
Since co-founding the company in 2006, Patrick has led the steady growth of the company toward becoming a leading choice for ophthalmology pharmaceutical and biotech…Read More
Dr. Weiss is a board-certified ophthalmologist and the Founder of Chicago Eye Consultants. He is an Assistant Professor of Ophthalmology at Rush University Medical Center,…Read More
Daniel A. de Boer is a Dutch serial entrepreneur and the founding Chief Executive Officer of ProQR Therapeutics since the company’s incorporation in 2012. When…Read More
Dr. Mark Wieland is the president of Northern California Retina Vitreous Associates, one of the premier and largest vitreoretinal practices in the Bay Area. He…Read More
Dr. Csaky’s main areas of interest are studying both clinical research and drug delivery development as it pertains to retinal diseases. In particular Dr. Csaky…Read More
Dr. Grunberg is a Managing Director of Longitude Capital. Prior to joining Longitude Capital in 2012, Dr. Grunberg was a Principal at Rho Ventures and…Read More
Dr. David Kirn a clinician-scientist, senior biotechnology, and entrepreneur who has extensive expertise in the areas of design, clinical research, and development of oncolytic viruses,…Read More
Dr. Pinakin Davey is a tenured Professor and Director of Research at Western University of Health Sciences, College of Optometry. He holds Doctor of Optometry…Read More
An experienced technology executive and entrepreneur, Jay has a strong track record of founding, growing, and turning around businesses. He has completed several successful exits…Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.